ABSTRACT
Extracellular nucleotides are used as signaling molecules by several cell types. In epidermis, their release is triggered by insults such as ultraviolet radiation, barrier disruption and wounding and by specific nerve terminals firing. Increased synthesis of hyaluronan, a ubiquitous extracellular matrix glycosaminoglycan, also occurs in response to stress, leading to the attractive hypothesis that nucleotide signaling and hyaluronan synthesis could also be linked.
In HaCaT keratinocytes ATP caused a rapid and strong but transient activation of hyaluronan synthase 2 (HAS2) expression via PKC-, CaMKII-, MAPK-and CREB-dependent pathways by activating the purinergic P2Y 2 receptor. Smaller but more persistent upregulation of HAS3 and CD44, and delayed upregulation of HAS1 were also observed. Accumulation of peri-and extracellular hyaluronan followed 4-6 h after stimulation, an effect further enhanced by the hyaluronan precursor glucosamine. AMP and adenosine, the degradation products of ATP, markedly inhibited HAS2 expression and, despite concomitant upregulation of HAS1 and HAS3, inhibited hyaluronan synthesis. Functionally, ATP moderately increased cell migration, whereas AMP and adenosine had no effect.
Our data highlight the strong influence of adenosinergic signaling on hyaluronan metabolism in human keratinocytes. Epidermal insults are associated with extracellular ATP release, as well as rapid upregulation of HAS2/3, CD44 and hyaluronan synthesis, and we show here that the two phenomena are linked. Furthermore, as ATP is rapidly degraded, the opposite effects of its less phosphorylated derivatives facilitate a rapid shut-off of the hyaluronan response, providing a feedback mechanism to prevent excessive reactions when more persistent signals are absent.
INTRODUCTION
ATP is the classical energy currency of live cells. In addition, it serves as an important signal transmitter in various tissues, including the epidermis [1, 2] , and between tissues, particularly the nervous system and target organs [3] . It is released in response to mechanical stimulation [4] , temperature stress [2] , and chemical receptor stimulation [5] by direct cell lysis, exocytosis, or secretion via e.g. connexin hemichannels and pannexin channels [6] . ATP is also released after insults such as ultraviolet (UV) radiation [7, 8] and tissue wounding or skin barrier disruption [9, 10] .
Additionally, extracellular ATP mediates inflammatory signals [11, 12] and pain sensation (reviewed in [13] ).
ATP is released into the extracellular space at relatively high concentrations and degraded rapidly to ADP, AMP, and further to adenosine [14] , which, except for AMP, are known to activate specific receptors even in a self-sustaining manner [15] . ATP signals through both the ionotropic P2X (cation channels), and the metabotropic P2Y receptors, which activate intracellular second messengers via specific G protein activation. The initial discovery of the role of purinergic signaling in rapid responses regulating neurotransmission and secretion was later followed by observations that extracellular nucleotides also modulate long-term or trophic effects including cell proliferation, differentiation and migration (reviewed in [16] ). There are seven functional P2X receptors (P2X [1] [2] [3] [4] [5] [6] [7] , and eight P2Y receptors (P2Y 1-2 , P2Y 4 , P2Y 6 and P2Y [11] [12] [13] [14] ; [3] ). In addition, another family of metabotropic P1 receptors with four distinct members (A 1 , A 2A , A 2B and A 3 ) relays the effects of extracellular adenosine [3] . Besides ATP, the versatile P2Y family also utilizes other nucleotides and their derivatives: the main ligands also include UTP (P2Y 2 , P2Y 4 ), UDP (P2Y 6 ) and UDP-glucose (P2Y 14 ; see [3, 17] for more complete listings of the known agonists).
ADP and adenosine utilize the metabotropic P2Y and P1 receptors, respectively. The ADP receptor P2Y 1 and the ATP receptors P2Y 2 and P2Y 11 are coupled to G q/11 proteins. They activate PLC, resulting in the formation of diacylglycerol and IP 3 leading directly and indirectly, via Ca 2+ release from the endoplasmic reticulum through IP 3 receptor activation, to activation of PKC. The ADP receptors P2Y 12 and P2Y 13 couple with G i/o to inhibit adenylyl cyclase and cAMP production [18, 19] . Keratinocytes express several purinergic receptors from the P2Y and P2X families [7, 11, 20] . Of the P1-receptors, A 2B is the main subtype [21, 22] .
Interestingly, it appears that the expression of P2 receptors may depend on the differentiation status of the keratinocytes, as P2Y 1 and P2Y 2 are found mainly in the basal cell compartment, while P2X 5 is located in the basal and spinous layers, and P2X 7 is found in the stratum corneum [23] . Functionally, P2Y 2 is then associated with proliferation, P2X 5 with differentiation and P2X 7 with apoptosis.
The potency of ATP on the different purinergic receptors varies with measured EC 50 values ranging from 0.1 µM for P2X 1 to as high as 2-4 mM for P2X 7 [24] . For the P2Y family, EC 50 values are in the micromolar range for ATP, whereas nanomolar ADP may be effective, depending on the receptor [17] . However, determining concentration dependency is difficult due to the quick metabolism of the agonists as well as the differential expression levels of the receptors, which may also change rapidly in response to physiological stimuli. The potency data also depends on the endpoint measured: e.g. it has been noted, that adenosine is least effective in modulating cAMP levels through the P1 receptor A 2B , whereas all the family members produce similar responses with respect to MAP kinase activation (reviewed in [25] ).
Hyaluronan is composed of repeating disaccharides of D-glucuronic acid and N-acetyl-Dglucosamine. This linear polysaccharide is synthesized at the inner leaflet of the plasma membrane and translocated into the extracellular matrix by the synthesizing enzymes [26] . The three highly homologous mammalian hyaluronan synthases (HAS1-3; [27, 28] ) differ in tissue distribution, expressional regulation and synthetic activity [29, 30] . Hyaluronan can remain associated pericellularly via the synthases or specific receptors such as CD44, or be released to associate with other matrix molecules [31] .
Hyaluronan is abundant in the dermal connective tissues and the epidermis [32] . Epidermal hyaluronan synthesis is rapidly upregulated after tissue wounding [33] , disruption of the permeability barrier [34] and UVB exposure [35] . As extracellular nucleotides are similarly released after tissue injury, it is relevant to ask, whether these processes could be linked. Previous data on the effects of nucleosides and nucleotides on hyaluronan metabolism are scarce, but adenosine is known to upregulate HAS1 expression and hyaluronan secretion in gingival fibroblasts [36] and smooth muscle cells [37] , while UDP-Glc, UTP and UDP enhance HAS2 expression and hyaluronan synthesis in keratinocytes [38, 39] .
In this work we wanted to explore the role of ATP and its metabolites in hyaluronan metabolism and signaling in human keratinocytes. Our data indicate that extracellular ATP and its degradation products AMP and adenosine are potent regulators of HAS2, enabling a rapid launch and shut-off of hyaluronan synthesis, depending on nucleotide release and degradation.
Furthermore, the upregulation of HAS2 seemed to depend heavily on the activation of the purinergic P2Y 2 receptor and downstream signaling cascades involving the calcium-activated PKC, CaMKII and CREB as well as the MAP kinases p38 and pERK. Overall, our data shed light on the complex regulation of HA synthesis in keratinocytes under simulated stress conditions.
MATERIALS AND METHODS
Cell culture -HaCaT, a spontaneously immortalized human epidermal keratinocyte cell line developed by Fusenig and colleagues [40] , were cultured in DMEM (Sigma-Aldrich, Inc., St. Louis, MO) containing 10% FBS (GE Healthcare Life Sciences/HyClone, Logan, UT), 2 mM L-glutamine (EuroClone, Milan, Italy), 50 units/ml penicillin and 50 μg/ml streptomycin (EuroClone). The same base medium was used when treating the cells with the different nucleotides, siRNAs and chemical inhibitors, unless otherwise specified. Supplementary Table S1 . Fold inductions were calculated using the formula 2 (-Ct) , where C t is C t(sample replicate) -C t(non-treated replicate) , C t is C t(gene of interest) -C t(ARP0) and C t is the cycle at which the detection threshold is crossed.
Western blotting -Proteins were extracted by incubating the cultures on ice for 30 min with RIPA lysis buffer (150 mM NaCl, 50 mM Tris, 1% Nonidet P-40, 0.5% sodium deoxycholate and 0.1% SDS) containing 10 mM NaF, 1% phosphatase inhibitor cocktail 2, and 0.5% protease inhibitor cocktail (Sigma-Aldrich). Protein content was measured using the Bradford assay [41] .
Samples containing 6.5-7.5 µg total protein were resolved by 10% SDS-PAGE followed by transfer were collected for hyaluronan quantification after 4, 6 or 24 h. Cells were released with trypsin and counted for data normalization. A sandwich-type enzyme-linked sorbent assay for hyaluronan measurement (HA-ELSA) was performed as described previously [42] .
Quantification of hyaluronan nucleotide sugar precursors by HPLC -HaCaT cells on 10-cm dishes were treated with 100 µM ATP for 1.5, 3, or 4.5 hours. Cells were extracted and nucleotide sugars measured as described previously [43] . Briefly: The cells were washed twice with and scraped into ice-cold PBS, sonicated and centrifuged. The samples were purified with Superclean Envi-Carb SPE-tubes (Sigma-Aldrich) followed by vacuum centrifugation. The dried samples were dissolved in water and analyzed by anion exchange HPLC (CarpoPac™ PA1 column; Dionex/Thermo Fisher Scientific) as described previously [43] . Total protein was measured with a Pierce BCA kit (Thermo Fisher Scientific) for normalization of the data.
Hyaluronan staining -For visualization of cell-associated hyaluronan, the cells were fixed for 20 min in 2% paraformaldehyde, permeabilized and blocked for 10 min using 0.1% Triton X-100 in 0.1 M phosphate buffer pH 7.0 (PB), containing 1% BSA. The cultures were incubated overnight at 4°C with a biotinylated hyaluronan binding complex (bHABC, 3 µg/ml; prepared in-house as described previously [44] ) and subsequently for 1 h at room temperature with the ABC reagent To analyze differences in migration rates, HaCaT cells were seeded on 24-well plates at 80.000-160.000 cells/well. After 2 days of culture, a cross-shaped area was scraped in each well with a sterile 1 ml pipette tip to get a wound devoid of cells, and fresh medium containing 1% serum with or without 10 µM ATP, AMP or adenosine was changed. The control and the nucleotide-treated cells (6-8 parallel wells/treatment) were photographed immediately and 6 h and 24 h after wounding using an Olympus CK2 inverted phase contrast microscope (4x objective) and a Nikon Digital Sight DS-L1 camera system. The distance the cells migrated was analyzed using the ImageJ software (National Institutes of Health, USA; http://imagej.nih.gov/ij).
Statistical methods -
The results were analyzed with PASW Statistics 18 (SPSS Inc., Chicago, IL). Log-or ln-transformation was used if the data was not normally distributed or the variances were unequal, or the non-parametric Friedman test was chosen. Mixed model ANOVA was applied, and pairwise comparisons between the treatments were performed using the estimated marginal means (LSD) or Dunnett's test. The controls (set as 1) and treatments were compared using the cumulative distribution function p-norm in R for Mac OS X, version 3.2.3 [45] . The results were corrected for multiple comparisons. The one-sample t-test was used for comparisons of a single treatment normalized to control (set as 1). Statistical significances are indicated as * ,#, § P < 0.05, ** ,##, § § P < 0.01 and ***,###, § § § P < 0.001. The data represent means and SEM, unless otherwise indicated.
RESULTS

Extracellular ATP strongly upregulates HAS2 expression in HaCaT keratinocytes -
Treating HaCaT with ATP for 2 h strongly upregulated HAS2 expression (Fig. 1A ) in a dosedependent fashion (Fig. 1B) . As the response with 100 µM was robust and slightly larger than with 10 µM, the higher concentration was used in most subsequent experiments with ATP and its metabolites. Maximum induction occurred at 1.5 h, and subsided to a 50% inhibition at 6 h (Fig.   1C ). Another stimulation was seen at 24 h (Fig. 1C ).
There were no significant changes in the expression of HAS1, HYAL1-2 or CD44 at 2 h (Fig.   1A ), but HAS1 increased later, at 6 h ( Fig. 1D) . ATP also caused a modest increase in the expression of HAS3, starting at 2 h (Fig. 1A) , and the transcript remained elevated (Fig. 1E ). CD44
showed a pattern similar to that of HAS3, being significantly upregulated at 4-6 h (Fig. 1F) .
Metabolites of ATP differentially regulate HAS expression -Like ATP, ADP (100 µM)
strongly upregulated HAS2 mRNA expression ( Fig. 2A) . In contrast, the further dephosphorylated AMP downregulated HAS2 at 2 h (range: 0.27-0.85; n = 12, P = 0.0001). This inhibitory effect persisted for at least 6 h, but after 24 h HAS2 expression in the AMP-treated cells exceeded the controls (Fig. 2B ). AMP induced a strong expression of HAS1, which peaked at 4-6 h (Fig. 2C ), while the effects on HAS3 were more modest, with the transcript levels rising steadily towards 24 h (Fig. 2D ).
Resembling the effects of AMP, adenosine inhibited HAS2 at 2-6 h, whereas the transcripts were restored to control levels by 24 h (Fig. 2B) . The effect of adenosine on HAS1 expression was similar to AMP (Fig. 2C) , while it did not significantly affect HAS3 (Fig. 2D) . CD44 did not exhibit significant responses to either AMP or adenosine (Fig. 2E) .
ATP upregulates HAS2 expression predominantly via P2Y 2 , Ca 2+ , and MAPK signalling -
To test the involvement of the P2Y receptors in the HAS2 response, siRNAs and chemical inhibitors were applied. The efficiency of the P2Y 2 siRNA was 60% (Fig. 3A) , which was associated with a 68% reduction of the ATP-induced HAS2 upregulation (Fig. 3A) . This suggests that P2Y 2 was the dominant P2Y receptor in the HAS2-response, an idea strengthened by the negligible effect of the P2Y 11 inhibitor NF340 (Suppl. Fig. 1A ).
Next, ADP receptors were blocked to study whether ATP signals through them. MRS2179, which inhibits P2Y 1 , slightly suppressed the HAS2-response (Fig. 3B) . Inhibition of P2Y 12 and P2Y 13 with PTX, which releases the G i protein from the receptors [46] and effectively blocks G isignaling in HaCaT without exhibiting toxicity [38] , moderately inhibited the ATP-induced HAS2 upregulation (Fig. 3C) . Additionally, upregulation of HAS2 at 2 h by the unhydrolyzable ATPanalog ATPS was not significantly different from the ATP-induced response (Fig. 3D ). This suggests that the metabolites of ATP such as ADP are not required for the upregulation of HAS2 expression, and further supports the conclusion that P2Y 2 is the main receptor mediating the effect.
Adenosine, most probably acting via the P1 receptors [25] , showed a tendency to inhibit the ATP-response (Fig. 3D) . Additionally, ,-methylene ATP (AMP-PCP), an agonist of certain P2X
receptors and an efficient local stimulator of cAMP formation when converted to AMP and adenosine [47], had a minor suppressive influence on HAS2 transcription (Fig. 3D ).
Signal transduction from the G q/11 protein-coupled P2Y 2 3E ). Upstream, inhibitors of CaMKII (KN93) and PKC (BIM; bisindolylmaleimide I) almost totally abolished the ATP-response ( Fig. 3F and 3G ). The MAPK pathway (MEK/ERK and p38) inhibitors PD98059 and BIRB796 also significantly suppressed the ATP-induced HAS2 upregulation (Fig.   3H ), while the JAK2/EGFR inhibitor AG490 was ineffective (Suppl. Fig. 1B ).
Western blotting was used to further characterize the effects of ATP: phosphorylations of p38, ERK, CREB and ATF-1 (another cAMP-dependent transcription factor) were clear and fast with maximum induction after 15-30 min (Fig. 4A-C) , while that of pSTAT3-Ser 727 was weaker, and pSTAT3-Tyr 705 appeared later, after 60-120 min (Suppl. Fig. 2A ). However, this activation of STAT3 was apparently not involved in the regulation of HAS2 expression, as its specific inhibitor STAT IX failed to counteract the ATP-induced increase in HAS2 mRNA (Suppl. Fig. 2B ).
ATP and AMP/adenosine have opposing effects on the hyaluronan content of human keratinocyte cultures -The influence of adenosine nucleotides on the hyaluronan content of
HaCaT cultures was analyzed with histochemical and biochemical assays. The histochemical stainings showed a clear increase of hyaluronan in the cell layer already 2 h after the application of 100 µM ATP (Fig. 5A-B) . Hyaluronan was mainly seen at the plasma membranes, colocalized (yellow color) with its receptor CD44, although an increase in the intracellular pool of HA was also evident ( Fig. 5D -E, D'-E'; 4 h after adding ATP, white arrowheads in 5E).
For the biochemical analyses, cells were cultured using medium containing 1% FBS, since medium supplemented with 10% FBS alone stimulated hyaluronan synthesis submaximally and almost overwhelmed the increase induced by ATP (data not shown). 4 h after adding 100 µM ATP the pericellular hyaluronan was augmented by 32%. After 6 h the peri-and extracellular hyaluronan pools were increased by 67% and 86%, respectively ( Fig. 6A-B) . At 24 h, there were no differences in either compartment. When the cultures were supplemented with 1 mM glucosamine to increase UDP-GlcNAc, a key substrate and activator of HAS2, hyaluronan content was increased even further both in the trypsinate and the medium (total increases with ATP and glucosamine: 216% and 173% after 6 h, respectively; Fig. 6C ). Glucosamine alone increased hyaluronan accumulation in the medium only by 37% (P < 0.05) and in the trypsinate by 43% (NS), indicating that both treatments are needed for a maximal effect.
Marked changes in hyaluronan stainings were not recognized after 2-4 h treatments with AMP and adenosine (Fig. 5C, 5F and 5F'). The inhibitory effect of AMP on HAS2 expression was not reflected in hyaluronan accumulation during a 6-h follow-up, while after 24 h a clear 41% reduction was observed in the medium (Fig. 6D ). Adenosine caused a significant 38% reduction in pericellular hyaluronan already at 6 h, and also suppressed hyaluronan content in the medium at 24 h by 36% (Fig. 6E ).
As intracellular hyaluronan precursor sugars influence HAS-activity (Fig. 6C ) [52] [53] [54] , we measured their concentrations with HPLC. UDP-GlcNAc was consistently decreased after 3-4.5 h in the ATP-treated cultures, whereas the UDP-glucuronic acid (UDP-GlcUA) pool was unaffected (Fig. 6F) .
ATP influences keratinocyte migration -Since increased hyaluronan synthesis and HAS2
expression [55, 56] have been connected to enhanced cell migration and proliferation, we tested the effects of ATP on keratinocyte numbers and migratory activity in scratch wound assays. 10 and 100
µM ATP did not significantly affect cell numbers after a 24-h treatment (Fig. 6G) , although the higher dose has been considered potentially growth-inhibiting [23] . In contrast, adenosine significantly lowered, and AMP had a tendency to suppress cell proliferation after a 24-h follow-up period with the 100 µM dose (Fig. 6G) . We then used for the migration assays the lower (10 µM) concentrations, which had no effect on proliferation. Treatment of the cells with this dose of ATP increased their motility by about 23% after a 6-h treatment (Fig. 6H) . However, by 24 h this effect had subsided (Fig. 6H) . Although adenosine showed a tendency to slow the early phase of scratch wound closure in 3 out of 4 experiments, the effect was not statistically significant ( Fig. 6H; after 6 h). After 24 h, no difference, as compared to the untreated cultures, were seen with either adenosine or AMP (Fig. 6H, after 24 h ).
Overall, our data indicate that extracellular ATP and its degradation products are potent regulators of keratinocyte HAS expression and hyaluronan synthesis as well as cell behavior, although with partially opposing effects. The signaling pathways most likely involved in the changed HAS expression are summarized in Figure 7 .
DISCUSSION
The present work shows for the first time that extracellular adenosine nucleotides are potent regulators of HAS expression. Importantly, ATP and the less phosphorylated AMP and adenosine often showed opposite influences on HAS expression, hyaluronan synthesis and keratinocyte functions, suggesting the existence of a regulatory loop based on ATP catabolism.
HAS expression and hyaluronan synthesis -ATP caused a rapid and very strong HAS2 upregulation, which was followed by a decline 4-6 h after the ATP exposure, concomitantly with increased HAS1 and HAS3 expressions. AMP and adenosine also upregulated HAS1 and HAS3 transcript levels; however, their influence on HAS2 was inhibitory. As hydrolysis of extracellular ATP is rapid in HaCaT [14] , the downregulation of HAS2 and the rise of HAS1 and HAS3 4-6 h after the ATP exposure may be caused by these degradation products.
ATP exposure was associated with a rapid increase in pericellular hyaluronan content and in the amount of hyaluronan released to the culture medium, in line with the observed changes in HAS mRNA expressions. However, the fold change in HAS2 mRNA with ATP was very high, actually higher than previously seen with potent stimuli such as growth factors or hormones [57] [58] [59] [60] , and compared to the HAS2 response the change in the hyaluronan content was relatively modest, suggesting that ATP may have caused other, perhaps posttranslational changes in HAS2 activity. It is also possible that the changes in the mRNA and protein levels do not correspond to each other under our experimental conditions, or that the residence and activity of the HAS2 protein at the plasma membrane does not reflect the true extent of the changes in its expression [54] .
Indeed, we observed that ATP reduced the level of UDP-GlcNAc after ~ 4 h. This could decrease hyaluronan synthesis through a lower precursor supply and by inhibiting the enzymatic activity due to reduced O-GlcNAcylation of HAS2 [61] . Extracellular ATP as well as adenosine can also signal for AMPK activation [62] , which can inhibit both the activity of HAS2 [63] and of GFAT1, the key enzyme in the hexosamine pathway towards UDP-GlcNAc [53, 64] . Indeed, supplementation of the cultures with glucosamine to enlarge the cellular pool of UDP-GlcNAc The release of ATP after various insults often seems to be an immediate response, but may also depend on the trigger. Thus, after UVB [7] and UVA irradiation [73] as well as stretching [74] the release occurs within seconds/minutes. After chemical irritation the release has been reported to occur within one hour, while after non-metal hapten exposure a longer period is required [75] .
The degradation of ATP in HaCaT cell cultures has been reported to occur rapidly reaching a stable level of approximately 50% during the first 40 min after the change of fresh medium (endogenous ATP), while a decline to ~ 60% has been found 1 h after exogenously added ATP [14] . Deduced from this more than half of the ATP is probably degraded within the 4-hour time frame, when the inhibitory effect on HAS2 and the stimulatory effect on HAS1 after ATP was observed, allowing time for signaling of the less phosphorylated derivatives.
Considering the signaling pathways, keratinocytes are known to express multiple purinergic receptors both from the P2Y and P2X families [7, 11, 20] . Experiments with siRNAs and chemical inhibitors indicated that P2Y 2 is the principal player in the ATP-induced HAS2 response, while P2Y 1 and P2Y 12/13 play minor roles. However, we cannot totally exclude contributions from the P2X-family, also expressed in epidermal keratinocytes.
AMP does not have unique receptors, but it could use A 1 , one of the receptors for adenosine [76] . However, inhibition of A 1 failed to prevent the AMP-induced HAS2 downregulation (unpublished observations), in line with its low expression in keratinocytes [22] . Therefore, it is likely that AMP influences HAS expression via conversion to adenosine.
At least under normal conditions [77] the main adenosine receptor in keratinocytes is A 2B
[21,22], the activation of which inhibits keratinocyte proliferation and causes cell cycle arrest through increased intracellular calcium [77] . A 2A , another adenosine receptor, little expressed in resting keratinocytes, is upregulated in psoriatic epidermis [77] , and by cytokines such as Il-1 and TNF, indicating that adenosine signaling shifts to this receptor under inflammatory conditions. This leads to cell proliferation via p38 signaling [77] . Since adenosine reduced cell numbers, the expression of the adenosine receptor A 2B rather than A 2A prevailed in the present experiments.
Intriguingly, if the expression of A 2A dominates, which can occur in stressed tissues [77] or malignancies [78] , activation of p38 signaling could increase the expression of HAS2, as observed in keratinocytes [35, 39] , and actually lead to increased hyaluronan production.
However, adenosine can also signal via receptor-independent mechanisms such as through adenosine uptake, followed by conversion to AMP with its intracellular signaling functions [79] , or by influencing membrane phosphatase activity [77] . The delayed responses, including the upregulation of HAS1 after 4-6 h and the secondary waves of HAS2 and HAS3 activation after 24 h, are likely processes secondary to the initial signals induced by the nucleotides. Interestingly, the induction seen in HAS1 with adenosine parallels the observations of Grandoch et al. [37] in human coronary artery smooth muscle cells, where HAS1 was most strongly upregulated after a 6-h treatment with the adenosine analog 5'-N-ethylcarboxamidoadenosine (NECA).
Extracellular ATP inherently induces Ca 2+ release and PKC signaling via the G q/11 -coupled P2Y-receptors [18], activating MAP kinases, CaMKII and CREB. The upregulation of HAS2 by CREB is anticipated since it has functional binding sites at the proximal HAS2 promoter [80] .
Additionally, CaMKII, p38 and ERK regulate HAS expression in response to radiation stress and growth factors [35, 55, 81, 82] , and p38 and ERK respond to extracellular ATP in human keratinocytes [83, 84] . Extracellular UTP, also released from stressed cells, causes an upregulation of HAS2 similar to that induced by ATP [39] . This is not surprising since they share P2Y 2 , the main P2 receptor involved in the HAS2 response. UTP and ATP also have many common signaling steps involved in the upregulation of HAS2, including MAP kinases, CaMKII and CREB [39] . However, ATP and UTP have also divergent effects on signaling, most obviously in STAT3 activation and its involvement in HAS2 upregulation [39] . This is probably explained by the contribution of receptors specific for each nucleotide, including P2Y 4 for UTP, P2Y 1 and P2Y 12/13 for ADP, and P2X for ATP. The difference in the signaling between ATP and UTP is signified by their divergent effects on HAS1 and HAS3 transcription, and the ability of AMP, but not UMP, to reduce HAS2 expression [39] .
Keratinocyte proliferation and migration -In addition to acting in the maintenance of extracellular matrices, HAS expression and hyaluronan content have been reported to regulate cell functions including proliferation, migration, differentiation and apoptosis [87] . The inhibition of hyaluronan synthesis induced by adenosine in HaCaT cells was associated with a reduction in cell numbers, in line with previous reports on human keratinocytes [21, 77] . Here, ATP did not clearly affect cell proliferation, which appears to depend on the experimental setup [20, 23, 88] .
However, ATP stimulated keratinocyte migration, and this coincided with the accumulation of hyaluronan after a 6-h ATP treatment. Such stimulation might be enough to keep keratinocytes activated and even repair minor epidermal damages, however, other factors are needed to mount a full wound healing response [89] . Although exogenous ATP has been shown to stimulate cell migration in many cell types such as in corneal epithelial cells [90] , its influence on keratinocyte motility has been controversial [91] , perhaps due to differences in the experimental conditions used.
Endogenously released ATP is more consistently stimulatory, regulating stretch-induced and basal migration [74] , as well as enhancing epithelial cell motility and wound closure [92] .
There is no previous information about the influence of adenosine on keratinocyte migration.
However, it stimulates motility in inflammatory cells and in breast cancer cells via autocrine activation of the A 3 receptor, but inhibits cell migration when added exogenously ( [93] , and references therein). The expression of this receptor is low in keratinocytes [77] , perhaps explaining why no change in migration was found. Actually, there was a tendency towards reduced migration at the early phase, coincidentally with the inhibition of HAS2 expression. However, adenosine may still play a positive role in skin wound healing since NECA, its nonspecific analog, has been shown to counteract corticosteroid-suppressed wound healing in a mouse model [94] .
Extracellular nucleotides and hyaluronan in epidermal biology -Extracellular nucleotides
are potent local danger signals that affect skin homeostasis through altered gene expression and matrix remodeling, as previously demonstrated in dermal fibroblasts during wound healing [95] .
Especially signaling via the P2Y 2 -receptor is implicated. The present data show that extracellular nucleotides regulate the synthesis of hyaluronan, a major component of the ECM in the epidermis [32] , through the same receptor.
During normal tissue homeostasis hyaluronan synthesis and degradation in the epidermis are active, but balanced [96] . However, whenever this homeostasis is disturbed with insults such as wounding, barrier disruption or UVB radiation, epidermal hyaluronan content is rapidly increased [33] [34] [35] , even within the first hour after the trauma [97] , together with other immediate defence reactions in the tissue. The strong but transient surge of HAS2 expression is obviously intended for a rapid response that can be augmented by other activators such as growth factors, hormones or cytokines, if the noxious condition prevails [98] [99] [100] . However, extracellular nucleotides may also play a role in the prolonged hyaluronan response because of the more widespread and/or increased expression of the P2Y 2 receptor induced by e.g. wounding and UVB [101, 102] .
As changes in HAS-expression and protein kinase activation elicited by UVB resemble those caused by the ATP-exposure [35, 103] , they may indeed be related to nucleotide signaling [8] .
However, while we have observed that the initial influences of UVB on rat keratinocyte Has2 and
Has1 [35] resemble those of adenosine on HaCaT, UVB-exposure causes Has2 to peak bimodally at 8 h and 36 h in a p38-dependent manner, perhaps due to a secondary release of ATP induced by the initial surge of extracellular nucleotides [104] or altered expression of the P2Y 2 receptor
[102, 105, 106] .
Functionally, the hyaluronan accumulation seen after ATP-treatment may protect cells from apoptosis, as shown in UV-stressed dermal fibroblasts [107] and corneal epithelial cells [108] .
Hyaluronan acting together with its receptor CD44 supports cell survival via AKT signaling, and CD44 may prevent apoptosis via counteracting ROS activity (reviewed in [109] ). Interestingly, the increased expression of CD44 seen after epidermal insults closely correlates with hyaluronan accumulation [33] , and this pattern was also seen here after the ATP exposure. 
Conclusions -
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